WallStSmart

Churchill Capital Corp XI (CCXI)vsHCM IV Acquisition Corp. Class A Ordinary Share (HACQ)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

HACQ leads profitability with a 0.0% profit margin vs 0.0%. CCXI earns a higher WallStSmart Score of 24/100 (F).

CCXI

Avoid

24

out of 100

Grade: F

Growth: 4.3Profit: 4.0Value: 5.0Quality: 6.0
Piotroski: 2/9

HACQ

Avoid

18

out of 100

Grade: F

Growth: 4.3Profit: 4.0Value: 5.0Quality: 4.8

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCXI0 strengths · Avg: 0/10

No standout strengths identified

HACQ0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

CCXI4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$677.31M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
4.7%3/10

ROE of 4.7% — below average capital efficiency

HACQ4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$374.12M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : CCXI

CCXI has a balanced fundamental profile.

Bull Case : HACQ

HACQ has a balanced fundamental profile.

Bear Case : CCXI

The primary concerns for CCXI are Revenue Growth, EPS Growth, Market Cap.

Bear Case : HACQ

The primary concerns for HACQ are Revenue Growth, EPS Growth, Market Cap.

Key Dynamics to Monitor

HACQ is growing revenue faster at 0.0% — sustainability is the question.

HACQ generates stronger free cash flow (-255,222), providing more financial flexibility.

Monitor SHELL COMPANIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CCXI scores higher overall (24/100 vs 18/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Churchill Capital Corp XI

FINANCIAL SERVICES · SHELL COMPANIES · USA

ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new drugs for inflammatory disorders, autoimmune diseases, and cancer in the United States. The company is headquartered in Mountain View, California.

HCM IV Acquisition Corp. Class A Ordinary Share

FINANCIAL SERVICES · SHELL COMPANIES · USA

HCM IV Acquisition Corp. (HACQ) is a prominent special purpose acquisition company (SPAC) focused on identifying and merging with high-growth technology firms that are well-positioned in the digital economy. Led by a seasoned management team with extensive experience in strategic transactions, HACQ aims to drive innovation and create value through its targeted investments. As the SPAC market continues to evolve, HACQ presents institutional investors with a unique opportunity to capitalize on the burgeoning sectors of disruptive technology and emerging market leaders.

Want to dig deeper into these stocks?